Reglagene, NeuroEM, Avery Therapeutics, and OncoMyx Therapeutics will deliver Company Presentations given by senior-level executives at the 2022 BIO International Convention in San Diego. Company Presentations showcase a company’s pipeline, R&D activities, business objectives, and investment goals. Continue reading
Author Archive: AZBio
Cutaneous Alpha-Synuclein Shown to Differentiate Parkinson’s from Related Neurological Disorders
A primary challenge in the diagnosis of neurological disorders is differentiating between conditions that share clinical features. Absent of a clear diagnosis, proper and effective patient care is hindered. Therefore, there is a great need for accessible diagnostic tools that help provide clarity to diagnosing clinicians.
Three Arizona Companies to Compete in the Start-Up Stadium at BIO2022
Start-Up Stadium provides start-up companies with the opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event. AZBio congratulates nVector, Inc., BacVax, Inc., and Nixxi for being selected to present at BIO2022.Continue reading
Nurses-On-Demand Provider, Navi Nurses, Awarded $1.5 Million To Support Patients Transitioning Home and Reimagine How Nurses Provide At-Home Care.
Nurse-led Pilot Funded by The American Nurses Foundation
Phoenix, Arizona, May 24th, 10:00 am MST: Phoenix-based startup Navi Nurses is one of 10 grantees to receive funding from the American Nurses Foundation as part of the Reimagining Nursing Initiative (RN Initiative). The American Nurses Foundation established the RN Initiative to support bold and innovative ideas developed and led by nurses to spark long-term change within health care. Out of the nearly 350 applicants, RN Initiative is supporting the boldest ideas with potential to revolutionize nursing.Continue reading
U.S. Secretary of Commerce Gina M. Raimondo Reestablishes the National Advisory Council on Innovation & Entrepreneurship (NACIE)
Thirty-two leaders and experts in technology, innovation, workforce development and academia have been appointed to the National Advisory Council on Innovation & Entrepreneurship (NACIE), the U.S. Department of Commerce announced today.Continue reading
Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries
- Pfizer will provide all its current and future patent-protected medicines and vaccines available in the U.S. or EU on a not-for-profit basis to 45 lower-income countries.
- Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to commit to join the Accord. Health officials in these countries will help identify and resolve hurdles beyond supply to inform the roll out in all 45 lower-income countries.
- Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap and help create a healthier world for 1.2 billion people.
CND Life Sciences Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias
Grant Supports the Evaluation of the Syn-One Test® to Help Clinicians Determine More Precise Diagnoses of Dementias at Early Stages of Cognitive ImpairmentContinue reading
TGen study offers path for late-stage cancer patients wanting to leverage their own health data to guide their care
PHOENIX, Ariz. — May 18, 2022 — For cancer patients nearing the end of standard of care treatment, data gleaned from their tumor genome and tissue samples can be an invaluable resource for seeking out future care. But how do patients safely access these data and obtain analyses to guide future personalized care?
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.
Continue reading
AZBio CEO Talks Medtech Opportunities on STEM Unplugged
Arizona’s MedTech sector continues to grow and play an integral role in the future of patient treatment. Tune in to this episode of STEM Unplugged to learn more about the role of AZBio and the opportunities to get involved with SciTech Institute. Kelly, Claire and Joan discuss the career pathways in MedTech.
Think about the advancing technology in Arizona and the role our future workforce plays in research. The guests discuss the importance of delivery and access to quality healthcare, too.Continue reading
Designer neurons offer new hope for treatment of Parkinson’s disease
The new study describes the implantation of induced pluripotent stem cells (iPSCs) to replace dopamine-producing neurons destroyed by Parkinson’s disease. Such cells not only survive the grafting procedure and manufacture dopamine, but send out their branching fibers through the neural tissue to make distant connections in the brain, just as their naturally-occurring counterparts.Continue reading